| Entry |
|
| Name |
Nerelimomab (USAN/INN) |
| Class |
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG01936 TNF inhibitor
|
| Efficacy |
Immunosuppressant, TNF inhibitor |
| Type |
Monoclonal antibody |
| Target |
|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
| Interaction |
|
| Brite |
Drug groups [BR:br08330]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG01936 TNF inhibitor
D05146 Nerelimomab
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokines
Tumor necrosis factors
TNF (TNFA, TNFSF2)
D05146 Nerelimomab (USAN/INN)
|
| Other DBs |
|
| LinkDB |
|